Clinical trials: Non-contact Mapping
Atrial Fibrillation
Characterising the Stable and Dynamic Left Atrial Substrate in Atrial Fibrillation
Atrial fibrillation (AF) is the most common sustained arrhythmia, with increasing prevalence associated with an ageing population.
- Trial name
- CASDAF-HD (NCT04229472)
- Testing
- High density electrophysiological mapping, Cardiac Magnetic Resonance Imaging
- Where
- United Kingdom
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Oxford University Hospitals NHS Trust
Paroxysmal Atrial Fibrillation
Electrical Coupling Information From The RHYTHMIA HDx Mapping System and DIRECTSENSE Technology In The Treatment of Paroxysmal Atrial Fibrillation (LOCALIZE CF)
The objective of this study is to evaluate whether local impedance (DIRECTSENSE™) drop on the INTELLANAV STABLEPOINT™ ablation catheter is associated with late pulmonary vein (PV) reconnections and durable conduction block in…
- Trial name
- LOCALIZE CF (NCT04740801)
- Testing
- Ablation procedure
- Where
- 5 sites in Germany, Italy and 1 more
- Volunteers
- 60 people
- Sponsor
- Boston Scientific Corporation
Atrial Fibrillation Mechanisms, Persistent Atrial Fibrillation
'Understanding the Electrophysiological Substrate Underlying Persistent Atrial Fibrillation Study II (USURP AF- Study II)'
Atrial fibrillation (AF) is the most common type of chronic heart rhythm disease worldwide, with significant associated co-morbidities.
- Conditions
- Atrial Fibrillation Mechanisms, Persistent Atrial Fibrillation, Substrate Ablation, Pulmonary Vein Isolation
- Trial name
- USURPAF (NCT04041778)
- Testing
- Catheter ablation
- Where
- United Kingdom
- Volunteers
- 17 people
- Sponsor
- University of Leicester